start portlet menu bar

Visualitzador de contingut web

Display portlet menu
end portlet menu bar

Clinical protection study of pseudorabies vaccine (AUSKIPRA® GN bartha k61 strain) in piglets infected with new Chinese PRV variant

Inici Coneixement Clinical protection study of pseudorabies vaccine (AUSKIPRA® GN bartha k61 strain) in piglets infected with new Chinese PRV variant

Clinical protection study of pseudorabies vaccine (AUSKIPRA® GN bartha k61 strain) in piglets infected with new Chinese PRV variant

Since 2011, several pseudorabies (PR) outbreaks have damaged Chinese swine industry. The purpose of this experiment is to test the efficacy of pseudorabies vaccine AUSKIPRA® GN (HIPRA) against new pseudorabies virus variant (AH02).

Sobre aquest article

Publicat en

APVS Congress, 2015

Autors

Zeng, R.; Wang, J.; Torrents, D.; Martinez, C.; Pedrazuela, R.; Galé, I.

Resum

In this study AUSKIPRA® GN reconstituted with RED solvent reduce mortality, lung lesions and fever. Therefore, AUSKIPRA® GN can provide clinical protection in front of new PRV strains.

Serveis relacionats

Productes relacionats

Compartir